Meta Infotech IPO to Open on July 4: Check Price Band, Timelines, and More

Meta Infotech Ltd, a prominent provider of comprehensive cybersecurity solutions and services, has launched its initial public offering (IPO) for public subscription today, i.e., July 4, 2025.

The company aims to raise ₹80.18 crore through this initial share sale, which is poised to conclude on July 8, 2025. The offering provides an opportunity to delve into the financials and strategic objectives of a cybersecurity entity seeking expansion on the BSE SME platform.

Key IPO Details: Timeline and Price Band

The ₹80.18 crore initial share sale is structured into two main components. It comprises a fresh issuance of equity shares valued at ₹20.04 crore, alongside an offer for sale (OFS) of 37.35 lakh shares worth ₹60.13 crore. The company had also secured ₹22.58 crore from anchor investors on July 3, 2025.

The price band for the IPO has been set at ₹153 to ₹161 per share. The lot size is 800 shares.

The basis of allotment is anticipated to be finalised on July 9, 2025, with the listing on the BSE SME platform scheduled for July 11, 2025.

Click here to explore other Upcoming IPOs

Allocation Structure

Individual investors are required to apply for at least two lots, which translates to 1,600 shares, amounting to ₹2,44,800.

High Net-Worth Individuals (HNIs) are required to apply for at least three lots (2,400 shares), amounting to ₹3,86,400.

Click here to check out newly Listed IPOs

Strategic Utilisation of Funds

The proceeds generated from the IPO are earmarked for several strategic purposes. Key objectives include the repayment of certain borrowings and funding capital expenditure necessary for establishing new office premises in Mumbai.

Additionally, a portion of the funds will be allocated towards setting up an interactive experience centre at the company's registered office, with the remaining capital intended for general corporate purposes.

Stakeholders in the Offering

Hem Securities has been appointed as the book-running lead manager for the issue. KFin Technologies will serve as the registrar, facilitating the IPO process. Hem Finlease is designated as the market maker for the offering.

Company Overview: Cybersecurity Solutions for a Digital India

Founded in 1998, Meta Infotech delivers end-to-end cybersecurity solutions, including cloud security, identity and access management, and endpoint protection. The company serves a diverse clientele across banking, IT, insurance, manufacturing, and other sectors.

As an authorised reseller for several global cybersecurity OEMs, Meta Infotech has positioned itself as a trusted partner for digital infrastructure protection in India.

Financial Performance and Growth

For the financial year ending March 31, 2025, Meta Infotech reported a revenue of ₹220.02 crore and a profit after tax of ₹14.50 crore, marking a 44% and 38% year-on-year growth, respectively. This robust financial performance underpins the company’s expansion plans and its ability to capitalise on the growing demand for cybersecurity services in India.

Strategic Rationale and Market Outlook

The IPO arrives at a time when cybersecurity is a critical priority for Indian enterprises amid rising digital adoption and regulatory focus on data protection. Meta Infotech’s strong revenue growth, diversified client base, and strategic use of IPO proceeds for infrastructure and technology upgrades position it well for future growth.

The listing on the BSE SME platform is expected to enhance the company’s visibility and access to capital markets.

Conclusion

Meta Infotech’s IPO offers investors an opportunity to participate in India’s expanding cybersecurity sector. With a competitive price band, clear utilisation of funds, and a proven track record of financial growth, the offering is set to attract significant attention from both retail and institutional investors as it progresses through the subscription window.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here